| 摘要 |
<p>1-Azaindolizine derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, wherein R1 represents -OR3 or -NHCOR4 (wherein R3 is C3-8 cycloalkyl, C1-6 alkyl substituted by C3-8 cycloalkyl, carboxyl-substituted C1-6 alkyl, or phenyl-substituted C1-6 alkyl, and R4 is C1-6 alkyl or C3-8 cycloalkyl); and R2 represents C1-6 alkyl (optionally substituted by two halogen atoms), C3-8 cycloalkyl, C5-10 alkenyl, or -(CH2)m-R5 (wherein m is 1 or 2 and R5 is C3-8 cycloalkyl, C1-6 alkoxy, or tetrahydrofuryl).</p> |
